Star Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Star Therapeutics is a clinical-stage biotechnology company focused on discovering and developing antibodies to address unmet needs in hematology and immunology. Its lead program, VGA039, is being developed as a potentially universal hemostatic antibody therapy that could treat multiple bleeding disorders, with von Willebrand disease highlighted as an initial target; the therapy is designed to be self-administered subcutaneously, aiming to reduce treatment burden for patients. Based in South San Francisco, California, the company operates within the biotechnology research sector and pursues antibody innovation to explore biological pathways that may support therapies across several diseases. The organization serves patients with bleeding and related conditions by advancing a portfolio of targeted antibody therapeutics through clinical development. Star Therapeutics has engaged in ongoing clinical and industry activities, including presenting at conferences and pursuing collaborations in its field, reflecting its position as a developing biopharmaceutical player in hematology and immunology.

Get verified Star Therapeutics emails free

Company overview Employee directory